Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.59 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | LCK | P06239 | 1/20 | 0.57 |
| ▸ | PPARD | Q03181 | 1/20 | 0.57 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.57 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.57 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.53 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.48 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.48 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.48 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27962408 | 1.00 | GPR84 (0.59) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL337640 | 1.00 | GPR84 (0.59) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL29868538 | 1.00 | GPR84 (0.59) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL28686565 | 1.00 | GPR84 (0.59) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL7744715 | 1.00 | GPR84 (0.59) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL464921 | 1.00 | GPR84 (0.59) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL6828481 | 1.00 | GPR84 (0.59) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL17688537 | 1.00 | GPR84 (0.59) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL3426343 | 1.00 | GPR84 (0.59) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL3815542 | 1.00 | GPR84 (0.59) | GPR84FFAR1MAPTLCKPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110283320-B | Synthesis method of antibacterial hydrogel capable of being hydrolyzed under weak alkaline | 浙江工业大学 | 2021-08-24 | — | — | CN | claimed |
| US-20260007779-A1 | CT CONTRAST AGENT FOR DETECTION OF CACHEXIA | UNIV GENEVE (CH) | 2026-01-08 | — | — | US | disclosed |
| US-12433963-B2 | CT contrast agent for detection of cachexia | UNIVERSITÉ DE GENÈVE; Adiposs SA (CH) | 2025-10-07 | — | — | US | disclosed |
| CN-113784734-B | CT contrast agent for detection of cachexia | 日内瓦大学 | 2024-09-27 | — | — | CN | disclosed |
| CN-118178688-A | CT contrast agent for detection of cachexia | 日内瓦大学 | 2024-06-14 | — | — | CN | disclosed |
| US-11654202-B2 | Nanoemulsion of iodinated fatty acids for CT imaging | UNIVERSITY OF GENEVA (CH) | 2023-05-23 | — | — | US | disclosed |
| CN-111194225-B | Nanoemulsion of iodinated fatty acids for CT imaging | 日内瓦大学（CH） | 2023-01-13 | — | — | CN | disclosed |
| US-20220160900-A1 | CT CONTRAST AGENT FOR DETECTION OF CACHEXIA | UNIVERSITÉ DE GENÈVE (CH) | 2022-05-26 | — | — | US | disclosed |
| CN-110283320-B | Synthesis method of antibacterial hydrogel capable of being hydrolyzed under weak alkaline | 浙江工业大学 | 2021-08-24 | — | — | CN | disclosed |
| EP-1502764-B1 | INFORMATION RECORDING/DISPLAYING CARD, IMAGE PROCESSING METHOD USING SAME, AND IMAGE PROCESSOR | RICOH CO LTD (JP) | 2014-05-07 | — | — | EP | disclosed |
| US-5585320-A | MULTICOLOR IMAGES | RICOH COMPANY, LTD. (JP) | 1996-12-17 | — | — | US | disclosed |
| US-5552364-A | HEAT SENSITIVE COLOR RECORDING METHOD FOR MULTICOLOR IMAGES | RICOH COMPANY, LTD. (JP) | 1996-09-03 | — | — | US | disclosed |
| US-5534907-A | Reversible thermosensitive coloring recording method, recording medium and recording apparatus for the recording method | RICOH COMPANY, LTD. (JP) | 1996-07-09 | — | — | US | disclosed |
| EP-0492628-B1 | Reversible thermosensitive coloring composition, recording medium, recording method and image display apparatus using the recording medium | RICOH KK (JP) | 1996-07-03 | — | — | EP | disclosed |
| US-5521138-A | COLOR DEVELOPMENT AND CRYSTALLIZATION | RICOH COMPANY, LTD. (JP) | 1996-05-28 | — | — | US | disclosed |
| US-5432534-A | Reversible thermosensitive coloring composition, recording medium, recording method, and image display apparatus using the recording medium | RICOH COMPANY, LTD. (JP) | 1995-07-11 | — | — | US | disclosed |
| US-5395433-A | Containing electron donor coloring and electron acceptor compounds which react to induce color formation; printers for computers, facsimile apparatus | RICOH COMPANY, LTD. (JP) | 1995-03-07 | — | — | US | disclosed |
| US-5296439-A | Support with reversible thermosensitive coloring recording layer containing electron donor coloring compound, electron acceptor which reacts to induce color formation | RICOH COMPANY, LTD. (JP) | 1994-03-22 | — | — | US | disclosed |
| EP-0576015-A1 | Method of reversible recording | Ricoh Company, Ltd (JP) | 1993-12-29 | — | — | EP | disclosed |
| EP-0492628-A1 | Reversible thermosensitive coloring composition, recording medium, recording method and image display apparatus using the recording medium | Ricoh Company, Ltd (JP) | 1992-07-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260007779-A1 | CT CONTRAST AGENT FOR DETECTION OF CACHEXIA | CPT1B, PNLIP, CPT1A | GPR84 446/4885FFAR1 40/4885MAPT 3977/4885 |
| US-11654202-B2 | Nanoemulsion of iodinated fatty acids for CT imaging | FABP1, FABP3, FABP4 | GPR84 72/4885FFAR1 19/4885MAPT 2391/4885 |
| US-20220160900-A1 | CT CONTRAST AGENT FOR DETECTION OF CACHEXIA | FABP4, FABP6, TNNC1 | GPR84 129/4885FFAR1 679/4885MAPT 4159/4885 |
| US-12433963-B2 | CT contrast agent for detection of cachexia | FABP4, FABP6, TNNC1 | GPR84 129/4885FFAR1 679/4885MAPT 4159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.